agendia

January 13, 2020January 13, 2020

Certain Genomic Tests May Soon Be Reimbursable for Breast Cancer Patients in Germany

News

Techniker Krankenkasse, one of the largest healthcare insurers in Germany, will begin reimbursing their breast cancer patients for genomic tests, announced Agendia, a diagnostics company that offers a test called MammaPrint. ... Read more

December 13, 2017

Curie Institute Is Partnering with Agendia on Breast Cancer Test Processing Study

News

The Institut Curie in Paris is teaming up with Agendia to examine the feasibility of cancer centers rather processing the genetic tests that the company developed to predict breast cancer outcomes. At the moment the processing ... Read more

May 5, 2017May 5, 2017

Full Interview with Agendia’s CMO on MammaPrint 70-gene Signature Test

News

Breast Cancer News, in an email exchange, interviewed Dr. William Audeh, chief medical officer of Agendia and a breast medical oncologist with nearly 30 years of clinical practice experience, to know more ... Read more

May 5, 2017May 8, 2017

MammaPrint Genomic Test Helps Early Stage Cancer Patients Safely Avoid Chemo, Agendia’s CMO Says

News

A genomic test, evaluated in several clinical trials and approved for use in the U.S. and Europe, can effectively tell early stage breast cancer patients what is their risk of cancer returning. ... Read more

April 29, 2016April 29, 2016

Agendia’s Genomic Risk Assay Cuts Need for Chemotherapy in Early Breast Cancer Patients by 46% in Phase 3 Trial

News

Agendia, Inc., announced initial positive results of a clinical trial investigating a genomic assay’s ability to accurately predict the need for chemotherapy in early stage breast cancer patients thought at risk of disease reoccurrence. The ... Read more

September 15, 2014September 17, 2014

Agendia Genomic Test for Molecular Subtyping of Breast Cancer Is a Better Guide to Pre-Surgical Treatment Study Finds

News

A new study entitled “Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)“ and published in the Annals of Surgical Oncology, ... Read more

September 4, 2014September 4, 2014

Molecular Subtyping Genomic Test Better for Breast Cancer, Agendia Study Says

Breast Cancer News, News

A surgical oncologist from Nashville and his team of fellow researchers recently published an observational study that compares two types of presurgical assessment tests for breast cancer patients. One of ... Read more